Late-Breaking Abstracts Announced for the Society for Immunotherapy of Cancer's 36th Annual Meeting – PR Web

writeDate(1033);
MILWAUKEE (PRWEB) November 01, 2021
The Society for Immunotherapy of Cancer (SITC) received a record-breaking number of abstract submissions in 2021, and has announced titles and authors for late-breaking abstracts (LBA). The abstracts will be presented at SITC’s upcoming 36th Annual Meeting & Pre-Conference Programs taking place November 10–14, 2021, in Washington, D.C.
“SITC is pleased to incorporate these abstracts into an already stellar schedule. The late-breaking abstracts will round out the content offered at the 36th Annual Meeting and highlight more recent data and research,” said SITC President Patrick Hwu, MD.
The late-breaking abstracts are:

Caddie Dy Laberiano, MD – The University of Texas MD Anderson Cancer Center

Sarah E. Church, PhD – NanoString Technologies

Enkhtaivan Gansukh, PhD – Virocure Inc.

Hans Wildiers, MD – University Hospitals Leuven; Department of General Medical Oncology and Multidisciplinary Breast Centre

Tianhong Li, MD, PhD – University of California at Davis

John M. Kirkwood, MD – University of Pittsburgh Medical Center

Kim A. Reiss, MD — University of Pennsylvania

Daniela A. Bota, MD, PhD – University of California Irvine

Patrick Danaher, PhD – NanoString

Wenliang Dong, PhD, MBA – ORCA Therapeutics BV

James Burke, MD – CG Oncology

Ignace Vergote, MD – University Hospitals Leuven, Leuven Cancer Institute

Mehmet Altan, MD – The University of Texas MD Anderson Cancer Center

Andreas Mackensen, MD – University Hospital Erlangen

Martin Wermke – University Hospital Dresden

Osama E. Rahma, MD – Dana-Farber Cancer Institute

Iván Márquez-Rodas, MD, PhD – Hospital Universitario Gregorio Marañón

Stephanie T. Schmidt, PhD – The University of Texas MD Anderson Cancer Center
The full abstracts will be available on Nov. 9 at 8 a.m. EST in the Journal for ImmunoTherapy of Cancer (JITC) supplement.
Late-Breaking Abstract Sessions with oral abstract presentations will take place on Friday, Nov. 12 from 12:10–12:40 p.m. EST and Saturday, Nov. 13 from 12–12:30 p.m. EST. Late-Breaking Abstract posters will be presented in the Poster Hall in Washington D.C. and the virtual ePoster Hall beginning Friday, Nov. 12 at 7 a.m. EST.
To learn more about the late-breaking abstracts, visit the 36th Annual Meeting & Pre-Conference Programs website.
About SITC
The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. Established in 1984, SITC, a 501(c)(3) not-for-profit organization, serves scientists, clinicians, academicians, patients, patient advocates, government representatives and industry leaders from around the world. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word cure a reality for cancer patients everywhere. To learn more, visit http://www.sitcancer.org and follow us on Twitter, LinkedIn, Facebook and YouTube.
Share article on social media or email:
View article via:
Questions about a news article you’ve read?
Reach out to the author: contact and available social following information is listed in the top-right of all news releases.
Questions about your PRWeb account or interested in learning more about our news services?
Call PRWeb:1-866-640-6397
©Copyright 1997-2015, Vocus PRW Holdings, LLC. Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

source